| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.04 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |